Q2 2017 EPS Estimates for Henry Schein Inc. (HSIC) Decreased by Analyst
Henry Schein Inc. (NASDAQ:HSIC) – Equities researchers at Northcoast Research cut their Q2 2017 earnings estimates for shares of Henry Schein in a research note issued to investors on Thursday. Northcoast Research analyst E. Snyder now anticipates that the brokerage will post earnings per share of $1.77 for the quarter, down from their prior estimate of $1.78. Northcoast Research also issued estimates for Henry Schein’s Q3 2017 earnings at $1.84 EPS, Q4 2017 earnings at $2.05 EPS and FY2017 earnings at $7.26 EPS.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.63 by $0.01. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The business earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.85 billion. During the same period in the prior year, the firm posted $1.46 EPS. Henry Schein’s quarterly revenue was up 9.3% compared to the same quarter last year.
A number of other research firms have also recently commented on HSIC. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, August 8th. Bank of America Corp. initiated coverage on Henry Schein in a report on Monday, September 12th. They set a “buy” rating and a $185.00 price target for the company. Robert W. Baird reiterated an “outperform” rating and set a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a report on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a report on Tuesday, October 11th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $159.50.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/q2-2017-eps-estimates-for-henry-schein-inc-hsic-decreased-by-analyst.html
Henry Schein (NASDAQ:HSIC) opened at 153.36 on Monday. The firm has a market capitalization of $12.54 billion, a PE ratio of 25.98 and a beta of 1.05. Henry Schein has a one year low of $142.64 and a one year high of $183.00. The stock has a 50 day moving average price of $162.17 and a 200-day moving average price of $170.06.
In other news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total value of $554,585.43. Following the completion of the sale, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.27% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Henry Schein by 2.2% in the second quarter. Vanguard Group Inc. now owns 7,493,463 shares of the company’s stock valued at $1,324,844,000 after buying an additional 161,065 shares in the last quarter. BlackRock Fund Advisors increased its position in shares of Henry Schein by 2.4% in the second quarter. BlackRock Fund Advisors now owns 2,369,132 shares of the company’s stock valued at $418,863,000 after buying an additional 55,384 shares in the last quarter. Janus Capital Management LLC increased its position in shares of Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock valued at $358,522,000 after buying an additional 286,929 shares in the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock valued at $141,865,000 after buying an additional 286,976 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Henry Schein by 4.1% in the first quarter. Geode Capital Management LLC now owns 772,565 shares of the company’s stock valued at $133,135,000 after buying an additional 30,593 shares in the last quarter. Institutional investors and hedge funds own 92.03% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.